CHILDRENS HOSPITAL LOS ANGELES
Patent Owner
Stats
- 29 US PATENTS IN FORCE
- 9 US APPLICATIONS PENDING
- Mar 06, 2018 most recent publication
Details
- 29 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,324 Total Citation Count
- May 19, 1989 Earliest Filing
- 39 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0188,886 METHOD, SYSTEM AND SOFTWARE FOR ASSESSING EXTUBATION FAILUREMay 28, 15Jul 06, 17[A61B, G06F]
2016/0317,619 USE OF NEUREGULIN-4 FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND NECROTIZING ENTEROCOLITISApr 26, 16Nov 03, 16[A61K, G01N]
2016/0166,192 MAGNETIC RESONANCE IMAGING TOOL TO DETECT CLINICAL DIFFERENCE IN BRAIN ANATOMYJul 30, 14Jun 16, 16[A61B]
2016/0017,318 GENE SIGNATURES TO IDENTIFY MOLECULAR SUBGROUPS IN MEDULLOBLASTOMA TUMORSJul 21, 15Jan 21, 16[C12N]
2011/0256,110 AMNIOTIC FLUID CELLS AND USES THEREOFOct 23, 09Oct 20, 11[A61K, C12Q, C12N, G01N, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9580451 Sulfonic esters of metal oxides and methods of their useJan 26, 15Feb 28, 17[A61K, C07F, C07D]
9352023 Use of neuregulin-4 for treatment of inflammatory bowel disease and necrotizing enterocolitisAug 15, 12May 31, 16[A61K]
9353366 Asparaginase and treating diseases associated with asparagine dependenceMay 07, 15May 31, 16[A61K, C12N]
9173590 Method and system for quantitative renal assessmentMay 17, 11Nov 03, 15[A61K, G06T, A61B, A61M]
9051561 Asparaginase and treating diseases associated with asparagine dependenceOct 09, 12Jun 09, 15[A61K, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0081,110 ELECTROPHYSIOLOGICAL DIAGNOSIS AND TREATMENT FOR ASTHMAAbandonedJun 04, 12Mar 20, 14[A61B, A61N]
2012/0196,760 METHODS AND COMPOSITIONS FOR IDENTIFYING MODULATORS OF ANTI-TETHERIN ACTIVITY TO INHIBIT PROPAGATION OF VIRUSESAbandonedSep 04, 09Aug 02, 12[C12Q, C12N, C40B, C07K]
2012/0039,858 METHODS AND COMPOSITIONS FOR INHIBITING PROPAGATION OF VIRUSES USING RECOMBINANT TETHERIN CONSTRUCTSAbandonedOct 16, 09Feb 16, 12[A61K, C07H, C12N, A61P, C07K]
2011/0212,858 SYNTHETIC POLY D/L LYSINE FOR CONTROL OF DIRECTION AND RATE OF NEURITE GROWTH AND REGENERATIONAbandonedNov 13, 09Sep 01, 11[C12N, C40B]
2010/0311,765 METABOLIC DEGRADATION INHIBITORS FOR ANTI-HYPERPROLIFERATIVE AGENTSAbandonedSep 26, 08Dec 09, 10[A61K, A61P]
2010/0035,911 DRUG COMBINATIONS TO TREAT HYPERPROLIFERATIVE DISORDERSAbandonedMay 16, 07Feb 11, 10[A61K, A61P]
7537757 Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant EMAP IIExpiredDec 08, 00May 26, 09[A61K, C07K]
7398119 Assessing blood brain barrier dynamics or identifying or measuring selected substances, including ethanol or toxins, in a subject by analyzing Raman spectrum signalsExpiredMar 25, 03Jul 08, 08[A61B]
7264803 Methods and pharmaceutical formulations for the treatment of pulmonary hypertensionExpiredOct 21, 02Sep 04, 07[A61K]
6991788 Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependenceExpiredJan 21, 03Jan 31, 06[A61K]
6984379 Gene therapy by administration of genetically engineered CD34+ cells obtained from cord bloodExpiredApr 08, 94Jan 10, 06[A61K, C12N]
2005/0261,779 Expansible rod-type prosthesis and external magnetic apparatusAbandonedNov 17, 03Nov 24, 05[A61F, A61B]
6961599 Identifying or measuring selected substances or toxins in a subject using resonant raman signalsExpiredMar 25, 03Nov 01, 05[A61B]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
